• 1
    Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjöld B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002; 359: 90919.
  • 2
    Olsen O, Gøtzsche PC. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2001: CD001877.
  • 3
    Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. CMAJ 1992; 147: 147788.
  • 4
    Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50–59 years. J Natl Cancer Inst 2000; 92: 14909.
  • 5
    Forrest AP, Alexander FE. A question that will not go away: at what age should mammographic screening begin? J Natl Cancer Inst 1995; 87: 11959.
  • 6
    van Oortmarssen GJ, Habbema JDF, van der Maas PJ, de Koning HJ, Collette HJA, Verbeek ALM, Geerts AT, Lubbe JThN. A model for breast cancer screening. Cancer 1990; 66: 160112.
  • 7
    de Koning HJ, Boer R, Warmerdam PG, Beemsterboer PMM, van der Maas PJ. Quantitative interpretation of age-specific mortality reductions from the Swedish Breast Cancer-Screening Trials. J Natl Cancer Inst 1995; 87: 121723.
  • 8
    Miller AB, Howe GR, Wall C. The National Study of Breast Cancer Screening. Protocol for a Canadian randomized controlled trial of screening for breast cancer in women. Clin Invest Med 1981; 4: 22958.
  • 9
    MuirC, WaterhouseJ, MackT, PowellJ, WhelanS, eds. Cancer incidence in five continents. vol. V. Lyon: IARC, 1987.
  • 10
    Gaudette LA. Should population-based screening for breast cancer be extended to Canadian women aged 70–79? A model-based approach. Ottawa: School of Graduate Studies and Research, University of Ottawa, 2001. Dissertation.
  • 11
    WHO. World health statistics annual. Geneva: WHO, 1984.
  • 12
    de Koning HJ, Fracheboud J, Boer R, Verbeek ALM, Collette HJA, Hendriks JHCL, van Ineveld BM, de Bruyn AE, van der Maas PJ. Nation-wide breast cancer screening in the Netherlands: support for breast-cancer mortality reduction. National Evaluation Team for Breast Cancer Screening (NETB). Int J Cancer 1995; 60: 77780.
  • 13
    Press WH, Flannery BP, Teukolsky SA, Vetterling WT. Numerical recipes. The art of scientific computing (Fortran version). Cambridge: Cambridge University Press, 1989.
  • 14
    Miller AB, Baines CJ, Turnbull C. The role of the nurse-examiner in the National Breast Screening Study. Can J Public Health 1991; 82: 1627.
  • 15
    Baines CJ, Miller AB, Bassett AA. Physical examination—its role as a single screening modality in the Canadian National Breast Screening Study. Cancer 1989; 63: 181622.
  • 16
    Bobo JK, Lee NC, Thames SF. Findings from 752,081 clinical breast examinations reported to a national screening program from 1995 through 1998. J Natl Cancer Inst 2000; 92: 9716.
  • 17
    Oestreicher N, White E, Lehman CD, Mandelson MT, Porter PL, Taplin SH. Predictors of sensitivity of clinical breast examination (CBE). Breast Cancer Res Treat 2002; 76: 7381.
  • 18
    Kopans DB, Feig SA. The Canadian National Breast Screening Study: a critical review. Am J Roentgenol 1993; 161: 75560.
  • 19
    Gøtzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000; 355: 12934.
  • 20
    VainioH, BianchiniF, eds. IARC handbooks of cancer prevention. vol. 7. Breast cancer screening. Lyon: IARC, 2002.
  • 21
    Nyström L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Rydén S, Andersson I, Bjurstam N, Fagerberg G, Frisell J, Tabár L, Larsson LG. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 1993; 341: 9738.
  • 22
    Holmberg LH, Adami HO, Tabár L, Bergstrom R. Survival in breast cancer diagnosed between mammographic screening examinations. Lancet 1986; 2: 2730.
  • 23
    Tabár L, Chen HH, Duffy SW, Krusemo UB. Primary and adjuvant therapy, prognostic factors and survival in 1053 breast cancers diagnosed in a trial of mammography screening. Jpn J Clin Oncol 1999; 29: 60816.